GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (STU:BUWA) » Definitions » Cyclically Adjusted FCF per Share

Bio-Rad Laboratories (STU:BUWA) Cyclically Adjusted FCF per Share : €8.41 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Bio-Rad Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2025 was €3.160. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €8.41 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted FCF Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bio-Rad Laboratories was 93.80% per year. The lowest was -22.40% per year. And the median was 10.50% per year.

As of today (2025-05-23), Bio-Rad Laboratories's current stock price is €195.30. Bio-Rad Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €8.41. Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is 23.22.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 24.68. And the median was 56.50.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Cyclically Adjusted FCF per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 6.27 6.91 7.29 8.29

Bio-Rad Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 7.65 7.43 8.29 8.41

Competitive Comparison of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF falls into.


;
;

Bio-Rad Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.16/134.9266*134.9266
=3.160

Current CPI (Mar. 2025) = 134.9266.

Bio-Rad Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.192 100.684 0.257
201509 1.740 100.392 2.339
201512 0.248 99.792 0.335
201603 -0.997 100.470 -1.339
201606 1.371 101.688 1.819
201609 0.365 101.861 0.483
201612 1.575 101.863 2.086
201703 -2.986 102.862 -3.917
201706 0.978 103.349 1.277
201709 0.231 104.136 0.299
201712 1.213 104.011 1.574
201803 0.354 105.290 0.454
201806 1.449 106.317 1.839
201809 1.138 106.507 1.442
201812 1.488 105.998 1.894
201903 0.568 107.251 0.715
201906 3.909 108.070 4.880
201909 2.090 108.329 2.603
201912 4.107 108.420 5.111
202003 1.232 108.902 1.526
202006 2.186 108.767 2.712
202009 3.260 109.815 4.005
202012 6.678 109.897 8.199
202103 2.618 111.754 3.161
202106 3.613 114.631 4.253
202109 5.505 115.734 6.418
202112 3.354 117.630 3.847
202203 0.528 121.301 0.587
202206 1.141 125.017 1.231
202209 -0.562 125.227 -0.606
202212 1.377 125.222 1.484
202303 1.959 127.348 2.076
202306 1.994 128.729 2.090
202309 1.720 129.860 1.787
202312 1.234 129.419 1.287
202403 0.954 131.776 0.977
202406 1.812 132.554 1.844
202409 3.219 133.029 3.265
202412 2.771 133.157 2.808
202503 3.160 134.927 3.160

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Bio-Rad Laboratories  (STU:BUWA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=195.30/8.41
=23.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 24.68. And the median was 56.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Bio-Rad Laboratories Headlines

No Headlines